Expression and purification of recombinant human MCT-1 oncogene in insect cells

Isabel Pérez-Arellano1, Roberto Gozalbo-Rovira, Ana Isabel Martínez

  • 1Centro de Investigación Príncipe Felipe, Valencia, Spain. iperez@cipf.es

The Protein Journal
|January 16, 2010
PubMed

Insights

Researchers produced pure MCT-1 protein, a lymphoma oncogene target, using a baculovirus system. This provides a foundation for developing new therapies by enabling further structure-function studies of this important cancer protein.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • MCT-1 protein, encoded by an oncogene, is highly expressed in lymphomas.
  • Its PUA domain interacts with mRNA cap complexes, suggesting it as a therapeutic target.
  • Targeting MCT-1 may attenuate the malignant phenotype in lymphomas.

Purpose of the Study:

  • To express and purify 6xHis-tagged MCT-1 protein using a baculovirus expression system.
  • To characterize the purified MCT-1 protein and confirm its functionality.
  • To lay the groundwork for future structure-function studies of MCT-1.

Main Methods:

  • MCT-1 gene amplification via PCR from a human cDNA library.
  • Expression in insect cells using a baculovirus system and subsequent two-step purification.
  • Protein characterization using gel filtration, peptide mass fingerprinting, circular dichroism, and cap-binding assays.

Main Results:

  • High production level of MCT-1 protein (6 mg/L) was achieved.
  • Purified MCT-1 protein was confirmed to be properly folded and functional via cap-binding assays.
  • A 3D model of the PUA domain was constructed based on existing structures.

Conclusions:

  • A robust method for producing abundant, pure, and functional MCT-1 protein was established.
  • This purified protein source is crucial for future structure-function investigations.
  • The findings support MCT-1 as a viable therapeutic target in lymphoma treatment.

Related Concept Videos